Jagsonpal Pharmaceuticals Limited Stock (NSE:JAGSNPHARM)


INR 176.40
Today's Range
INR175.25 - INR180.60
52-Week Range
INR73.01 - INR267.00
Market Cap

About Jagsonpal Pharmaceuticals Limited (NSE:JAGSNPHARM)

(NSE:JAGSNPHARM) Jagsonpal Pharmaceuticals Limited develops and manufactures pharmaceuticals products and active pharmaceutical ingredients worldwide. It offers active pharmaceutical ingredients, which include allylestrenol, dextropropoxyphene HCL, dextropropoxyphene napsylate, disulfiram, thiopental sodium, thiopental acid, tolnaftate, and sildenafil citrate, as well as metformin HCL, BP, USP, and EP. The company also provides formulations for various therapeutic categories, such as anabolic steroids, analgesics, anesthetics, anti-allergic, anti-asthamatics, anti-cholinergic agents, anti-convulsants, anti-diabetics, anti-diarrhoeals, anti-emetics, anti-epileptics, anti-fungal agents, anti-gout agents, anti-inflammatory agents, anti-malarials, anti-nauseants, anti-protozoals, anti-pyretic, anti-rheumatic drugs, anti-spasmodic agents, and anti-septic agents. In addition, it offers anti-tubercular drugs, anti-ulcerants, anxiolytics, cardiovascular drugs, corticosteroids, cough syrups, diuretics, drugs for alcohol dependence, GI anti-infectives, haematinics, imaging agents, laxatives, male/female hormones, multivitamins, nutraceuticals, ophthalmic lubricants, oral rehydrating salts, sedative-hypnotics, softgels, systemic anti-infectives, throat pain sprays, tonics, and uterine stimulants. The company sells its products primarily under the Lycored, Maintane, Metadec, Metabol, Doxypal DR, Parvon, and Indocap SR brand names. Jagsonpal Pharmaceuticals Limited was founded in 1964 and is based in New Delhi, India. Jagsonpal Pharmaceuticals Limited is a subsidiary of Aresko Progressive Private Limited.
Show more


Statistics Highlights (NSE:JAGSNPHARM)

Shares Outstanding 26.20M Beta 1.24
Public Float 6.95M P/E Ratio 25.80
% Short of Float - Dividend (Yield) -
Held by Insiders 75.13% Ex-Dividend Date Oct 29, 2021
Held by Institutions - IPO Date -

JAGSNPHARM Financial Summary

Mar 21 Mar 20 Mar 19
Revenue INR1.88B INR1.59B INR1.67B
EBITDA INR233.86M INR109.28M INR104.63M
Net Income INR170.58M INR78.71M INR72.16M
Total Assets INR1.64B INR1.47B INR1.36B
Total Cash INR589.43M INR380.74M INR385.35M
Total Debt INR68.06M INR46.65M INR37.85M
Dec 21 Sep 21 Jun 21
Revenue INR544.74M INR594.89M INR599.99M
EBITDA INR75.65M INR105.66M INR100.96M
Net Income INR54.06M INR73.07M INR68.48M
Total Assets INR INR1.93B INR
Total Cash INR INR466.62M INR
Total Debt INR INR69.57M INR

JAGSNPHARM Stock Price History

Jagsonpal Pharmaceuticals Limited Annual Stock Price History

Year Open Close Change
2021 INR180.25 INR176.40 -2.14%
2021 INR72.00 INR180.25 150.35%
2020 INR25.00 INR72.00 188.00%

Jagsonpal Pharmaceuticals Limited Daily Stock Price History

Date Open High Low Close Change Volume
Jun 17, 2022 INR277.00 INR285.00 INR270.25 INR274.10 -6.90% 33.63K
Jun 14, 2022 INR294.95 INR302.45 INR290.05 INR294.40 -0.36% 35.01K
Jun 9, 2022 INR292.00 INR297.05 INR292.00 INR295.45 -2.23% 15.39K


What is today's stock price of Jagsonpal Pharmaceuticals Limited (NSE:JAGSNPHARM)?

  • The current stock price of Jagsonpal Pharmaceuticals Limited (NSE:JAGSNPHARM) is INR176.40.
  • Today JAGSNPHARM stock price opened at INR178.00 after previous close of INR179.25.
  • During the day, Jagsonpal Pharmaceuticals Limited stock quote has varied from a low of INR175.25 to a high of INR180.60.

What is Jagsonpal Pharmaceuticals Limited's 52-week change?

  • JAGSNPHARM 52-week high stock quote is INR267.00, which is 51.40% above the current share price.
  • The Jagsonpal Pharmaceuticals Limited (NSE:JAGSNPHARM) 52-week low stock price is INR73.01, which is 58.60% below the current share price.
  • Jagsonpal Pharmaceuticals Limited share price volatility (52-week beta) is 1.24.

Jagsonpal Pharmaceuticals Limited (NSE:JAGSNPHARM) FAQ

How Much is Jagsonpal pharmaceuticals limited Worth?

Jagsonpal pharmaceuticals limited's worth today based on market capitalisation is INR6.36B

How much dividend does Jagsonpal pharmaceuticals limited Pay?

The current annualized dividend payout for JAGSNPHARM stock is INR5.00, the dividend yield is 2.12% and the payout ratio is 53.13%.
View More Details on Jagsonpal pharmaceuticals limited's "Dividend" Section

What is Jagsonpal pharmaceuticals limited’s Price to Earning (PE) ratio?

Jagsonpal pharmaceuticals limited has a Price to Earning (P/E) ratio of 25.80. JAGSNPHARM stock also has a Price to Sales (P/S) ratio of 2.93.

What is the Jagsonpal pharmaceuticals limited's ticker?

Jagsonpal pharmaceuticals limited trades on the NSE stock market in India under the ticker symbol "JAGSNPHARM". Jagsonpal pharmaceuticals limited’s stock symbol can also be displayed as "NSE:JAGSNPHARM".

Who are the owners of Jagsonpal pharmaceuticals limited?

Jagsonpal pharmaceuticals limited (NSE:JAGSNPHARM) is owned by 0.00% institutional shareholders and by 75.13% insiders. The rest is owned by the public.
Explore More Details on Jagsonpal pharmaceuticals limited's “Ownership” Section

Who are the key executives of Jagsonpal pharmaceuticals limited (JAGSNPHARM)?

Jagsonpal pharmaceuticals limited's key executive team includes the following managers:

  • Mr. Rajpal P. Singh Kochhar, Chairman & MD (1955)
  • Ms. Nandita Singh, Company Sec. & Compliance Officer (NA)
  • Mr. S. V. Subha Rao, Chief Financial Officer (NA)
  • Mr. Prithipal Singh Kochhar, VP of International Bus. and International Marketing (1979)
  • Bharat Chugh, Assistant Gen. Mang. of HR (NA)

What is Jagsonpal pharmaceuticals limited’s Sector & Industry Classification?

Jagsonpal pharmaceuticals limited (NSE:JAGSNPHARM) is classified under the "Healthcare" sector and under the "Drug Manufacturers-Specialty & Generic" industry.

How many employees work for Jagsonpal pharmaceuticals limited?

Currently the number of employees working for Jagsonpal pharmaceuticals limited is 0.

Where are Jagsonpal pharmaceuticals limited's Headquarters?

Jagsonpal pharmaceuticals limited (NSE:JAGSNPHARM) is headquartered in India.

What are Jagsonpal pharmaceuticals limited's Address and Phone Number?

Jagsonpal pharmaceuticals limited’s mailing address is T-210 J, Shahpur Jat, New Delhi, India, 110049.
The company’s phone number is 91 11 4618 1100.

What is the official website for Jagsonpal pharmaceuticals limited?

Jagsonpal pharmaceuticals limited’s official website is http://www.jagsonpal.com